“Risk-Based” Enforcement Approach to Homeopathic Products Will Be Taken By Federal Regulators
The FDA has announced it will take a "risk-based" approach to enforcement of homeopathic products.
The FDA has announced it will take a "risk-based" approach to enforcement of homeopathic products.
The FDA has issued warning letters to four companies making injectable homeopathic drugs, saying they are unapproved products made with poor manufacturing standards.
The FDA has issued new guidance and made policy changes altering its enforcement of homeopathic products to focus on those with the highest risk to the public.
The FDA announced it has sent warning letters to the makers of homeopathic Puriton Eye Relief Drops, saying their manufacturing processes may make their products unsterile and unsafe to use.
The FDA is warning homeopathic drug manufacturers about the use of poor manufacturing processes and contamination.
The FDA has proposed new guidelines for addressing safety concerns linked to unproven and potentially dangerous homeopathic products.
The FDA has announced a recall of all lots of Hyland's Baby Teething Tablets and Hyland's Baby Nighttime Teething Tablets over concerns of belladonna poisoning.
Varying levels of belladonna have been found in several CVS homeopathic children's products for teething and earaches, resulting in a nationwide recall.
Hyland's has announced it is ending sales of its teething tablets and gels in the U.S. after the FDA warned that the homeopathic products may be harmful to children's health.
The FDA is considering new regulations on how homeopathic remedies are reviewed and sold following several safety recalls in recent years.